Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Lung cancer

Tumour-suppressive TANs identified in humans

Tumour-associated neutrophils (TANs) can be detected in the microenvironment of most tumours; however, the role of these cells has yet to be established. Now, an in vitro analysis of tumour biopsy and blood samples from patients with stage I–II lung cancer has identified a subset of TANs with a tumour suppressive role. These TANs expressed cell-surface proteins more typically observed on antigen-presenting cells (APCs), that were not detectable on neutrophils in patients' peripheral blood samples. An antigen-presenting role of APC-like TANs was then confirmed by the ability of these cells to trigger memory T-cell responses to HLA class I and class II epitopes. These cells were most commonly observed in the microenvironment of tumours <3 cm in diameter, but were absent in patients with tumours >7 cm, suggesting that APC-like TANs have a tumour suppressive effect.

References

  1. Singhal, S. et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell http://dx.doi.org/10.1016/j.ccell.2016.06.001 (2016).

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sidaway, P. Tumour-suppressive TANs identified in humans. Nat Rev Clin Oncol 13, 528 (2016). https://doi.org/10.1038/nrclinonc.2016.118

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2016.118

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing